Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
X25-03-ZQ351-1 |
PEG 350 Da |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-2 |
PEG 550 Da |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-3 |
PEG 750 Da |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-4 |
PEG 1 kDa |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-5 |
PEG 2 kDa |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-6 |
PEG 3 kDa |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-7 |
PEG 4 kDa |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-8 |
PEG 5 kDa |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-9 |
PEG 10 kDa |
Xanthan |
HAS |
Inquiry
|
X25-03-ZQ351-10 |
PEG 20 kDa |
Xanthan |
HAS |
Inquiry
|
Properties
Description
This protein conjugate features human serum albumin (HSA) linked to the polysaccharide xanthan via a polyethylene glycol (PEG) spacer, potentially enhancing biocompatibility, prolonging circulation, or providing a platform for drug delivery.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
HSA-PEG-xanthan is soluble in a wide range of organic solvents, such as DCM, DMF, and DMSO, and shows excellent solubility in water.
Identity
Confirmed by NMR.
Stability
The product is stable for 1 year when stored at the recommended temperature in powder.
Quality Level
Research grade
Applications
HSA-PEG-xanthan can be used to study protein interactions, stability, and potential for drug delivery.
Storage
Store at -20°C, protect from light.